Data from: Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle
Data files
May 13, 2026 version files 35.10 KB
-
E2_NS2-NS3_BVDV_Type_1a_nucleotide.txt
5 KB
-
E2_NS2-NS3_BVDV_Type_1a_protein.txt
1.68 KB
-
E2_NS2-NS3_BVDV_Type_1b_nucleotide.txt
4.94 KB
-
E2_NS2-NS3_BVDV_Type_1b_protein.txt
1.68 KB
-
E2_NS2-NS3_BVDV_Type_2_nucleotide.txt
4.93 KB
-
E2_NS2-NS3_BVDV_Type_2_protein.txt
1.67 KB
-
NS4-NS5_BVDV_Type_1_nucleotide.txt
5.06 KB
-
NS4-NS5_BVDV_Type_1_protein.txt
1.70 KB
-
NS4-NS5_BVDV_Type_2_nucleotide.txt
5.06 KB
-
NS4-NS5_BVDV_Type_2_protein.txt
1.71 KB
-
README.md
1.68 KB
Abstract
Bovine Viral Diarrhea Virus (BVDV) is a key contributor to the development of Bovine Respiratory Disease complex, which can cause respiratory disease, congenital defects, severe diarrhea, immunosuppression, abortion, or birth of persistently infected calves. Current commercial vaccines are formulated using strains from BVDV-1a and BVDV-2a, conferring protection against some, but not all, homologous species and low neutralization titers against heterologous and emergent species. This study aimed to develop a live vaccine capable of inducing broad protection against diverse BVDV strains. A contemporary live-attenuated BPI3Vc-vectored BVDV prototype vaccine was developed. Novel chimeric BVDV E2-NS2-51-2 antigens, designed based on the consensus of all BVDV-1a, -1b, -2a, -2b, and -2c protein sequences, were used to generate recombinant BPI3VcmutantE2-NS2-51-2 viruses. The recombinant viruses expressed all the 5kb encoded transgenes, replicated efficiently, remained genetically stable over nine passages in vitro, and displayed the E2 ectodomain on the surface of infected cells. Intranasal immunization of calves with a cocktail of these recombinant viruses, designated rBPI3VcmutBVDV, elicited strong serum antibodies against BVDV-1 and -2 viruses compared to a commercial vaccine. Notably, vaccination elicited stronger IgG responses against BVDV-1b CA0401186a and TGAC, with significantly higher virus-neutralizing titers than the commercial vaccine (CA0401186a: p=0.0031; TGAC: p=0.0002). Immunized calves also elicited significantly higher VN titers against BVDV-2a strains 296NC (p=0.0006), 890 (p=0.0020), 296C (p=0.0464), A125 (p=0.0018), and 1373 (p=0.0025). Upon challenge with BVDV-1b CA0401186a, the rBPI3Vcmut~BVDV vaccinees exhibited a steady weight gain, a slight decrease in lymphocyte counts, lower viremia, and fewer gross lesions. This data supports the use of the live-attenuated BPI3Vc-vector for the development of contemporary broadly protective BVDV vaccines that can easily be upgraded for improved disease management and cattle productivity.
Dataset DOI: 10.5061/dryad.83bk3jb7t
Description of the data and file structure
Files and variables
File: E2_NS2-NS3_BVDV_Type_1a_nucleotide.txt
Description: Nucleotide consensus sequence encoding novel BVDV Type 1a E2 and NS2-NS3 genes
File: E2_NS2-NS3_BVDV_Type_1a_protein.txt
Description: Protein consensus sequence encoding novel BVDV Type 1a E2 and NS2-NS3 protein
File: E2_NS2-NS3_BVDV_Type_1b_nucleotide.txt
Description: Nucleotide consensus sequence encoding novel BVDV Type 1b E2 and NS2-NS3 genes
File: E2_NS2-NS3_BVDV_Type_1b_protein.txt
Description: Protein consensus sequence encoding novel BVDV Type 1b E2 and NS2-NS3 protein
File: E2_NS2-NS3_BVDV_Type_2_nucleotide.txt
Description: Nucleotide consensus sequence encoding novel BVDV Type 2 E2 and NS2-NS3 genes
File: E2_NS2-NS3_BVDV_Type_2_protein.txt
Description: Protein consensus sequence encoding novel BVDV Type 2 E2 and NS2-NS3 protein
File: NS4-NS5_BVDV_Type_1_nucleotide.txt
Description: Nucleotide consensus sequence encoding novel BVDV Type 1 NS4-NS5 genes
File: NS4-NS5_BVDV_Type_1_protein.txt
Description: Protein consensus sequence encoding novel BVDV Type 1 NS4-NS5 protein
File: NS4-NS5_BVDV_Type_2_nucleotide.txt
Description: Nucleotide consensus sequence encoding novel BVDV Type 2 NS4-NS5 genes
File: NS4-NS5_BVDV_Type_2_protein.txt
Description: Protein consensus sequence encoding novel BVDV Type 2 NS4-NS5 protein
